Wake Forest Baptist Health Comprehensive Cancer Center is a clinical research site located in Winston-Salem, North Carolina, United States 27157.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Wake Forest Baptist Health Comprehensive Cancer Center has participated in 5 clinical trials with 3 currently active.
Therapeutic areas: Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF.
Sponsors: John Mascarenhas, Icahn School of Medicine at Mount Sinai, NewLink Genetics Corporation.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Wake Forest Baptist Health Comprehensive Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wake Forest Baptist Health Comprehensive Cancer Center has 5 clinical trials on record, with 3 currently active. Their work covers Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF.
Yes — Wake Forest Baptist Health Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.